{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,19]],"date-time":"2026-03-19T15:37:31Z","timestamp":1773934651453,"version":"3.50.1"},"reference-count":51,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,3,13]],"date-time":"2026-03-13T00:00:00Z","timestamp":1773360000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,3,19]],"date-time":"2026-03-19T00:00:00Z","timestamp":1773878400000},"content-version":"vor","delay-in-days":6,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Amino Acids"],"DOI":"10.1007\/s00726-026-03509-1","type":"journal-article","created":{"date-parts":[[2026,3,13]],"date-time":"2026-03-13T06:55:16Z","timestamp":1773384916000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Association between plasma concentrations of galectin 3, growth differentiation factor 15, soluble suppression of tumourigenicity 2, and cystatin C and clinical parameters and survival in patients with end-stage renal disease undergoing haemodialysis"],"prefix":"10.1007","volume":"58","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3051-8030","authenticated-orcid":false,"given":"Micha\u0142","family":"Ptak","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8211-0235","authenticated-orcid":false,"given":"Aleksandra","family":"Cader-Ptak","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zuzanna","family":"Marcinowska","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4809-415X","authenticated-orcid":false,"given":"Violetta","family":"Dziedziejko","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9415-2758","authenticated-orcid":false,"given":"Krzysztof","family":"Safranow","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9847-6589","authenticated-orcid":false,"given":"Ewa","family":"Kwiatkowska","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2758-8871","authenticated-orcid":false,"given":"Kazimierz","family":"Ciechanowski","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6557-1208","authenticated-orcid":false,"given":"Andrzej","family":"Pawlik","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4712-7821","authenticated-orcid":false,"given":"Leszek","family":"Doma\u0144ski","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,3,13]]},"reference":[{"key":"3509_CR1","doi-asserted-by":"publisher","first-page":"1578","DOI":"10.1093\/cvr\/cvy150","volume":"114","author":"R Altara","year":"2018","unstructured":"Altara R, Ghali R, Mallat Z, Cataliotti A, Booz GW, Zouein FA (2018) Conflicting vascular and metabolic impact of the IL-33\/sST2 axis. Cardiovasc Res 114:1578\u20131594. https:\/\/doi.org\/10.1093\/cvr\/cvy150","journal-title":"Cardiovasc Res"},{"key":"3509_CR2","doi-asserted-by":"publisher","first-page":"1448","DOI":"10.1373\/clinchem.2019.305797","volume":"65","author":"N Bansal","year":"2019","unstructured":"Bansal N, Zelnick L, Shlipak MG, Anderson A, Christenson R, Deo R, deFilippi C, Feldman H, Lash J, He J, Kusek J, Ky B, Seliger S, Soliman EZ, Go AS, CRIC Study Investigators (2019) Cardiac and stress biomarkers and chronic kidney disease progression: the CRIC study. Clin Chem 65:1448\u20131457. https:\/\/doi.org\/10.1373\/clinchem.2019.305797","journal-title":"Clin Chem"},{"key":"3509_CR3","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1016\/j.jacc.2013.07.087","volume":"63","author":"A Bayes-Genis","year":"2014","unstructured":"Bayes-Genis A, de Antonio M, Vila J, Pe\u00f1afiel J, Gal\u00e1n A, Barallat J, Zamora E, Urrutia A, Lup\u00f3n J (2014) Head-to-head comparison of 2 myocardial fibrosis biomarkers for long-term heart failure risk stratification: ST2 versus galectin-3. J Am Coll Cardiol 63:158\u2013166. https:\/\/doi.org\/10.1016\/j.jacc.2013.07.087","journal-title":"J Am Coll Cardiol"},{"key":"3509_CR4","doi-asserted-by":"publisher","first-page":"11514","DOI":"10.1073\/pnas.94.21.11514","volume":"94","author":"MR Bootcov","year":"1997","unstructured":"Bootcov MR, Bauskin AR, Valenzuela SM, Moore AG, Bansal M, He XY, Zhang HP, Donnellan M, Mahler S, Pryor K, Walsh BJ, Nicholson RC, Fairlie WD, Por SB, Robbins JM, Breit SN (1997) MIC-1, a novel macrophage inhibitory cytokine, is a divergent member of the TGF-beta superfamily. Proc Natl Acad Sci U S A 94:11514\u201311519. https:\/\/doi.org\/10.1073\/pnas.94.21.11514","journal-title":"Proc Natl Acad Sci U S A"},{"key":"3509_CR5","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1007\/s004410051337","volume":"297","author":"M B\u00f6ttner","year":"1999","unstructured":"B\u00f6ttner M, Suter-Crazzolara C, Schober A, Unsicker K (1999) Expression of a novel member of the TGF-beta superfamily, growth\/differentiation factor-15\/macrophage-inhibiting cytokine-1 (GDF-15\/MIC-1) in adult rat tissues. Cell Tissue Res 297:103\u2013110. https:\/\/doi.org\/10.1007\/s004410051337","journal-title":"Cell Tissue Res"},{"key":"3509_CR6","doi-asserted-by":"publisher","DOI":"10.3390\/biomedicines11061676","volume":"11","author":"G Brunetti","year":"2023","unstructured":"Brunetti G, Barile B, Nicchia GP, Onorati F, Luciani GB, Galeone A (2023) The ST2\/IL-33 pathway in adult and paediatric heart disease and transplantation. Biomedicines 11:1676. https:\/\/doi.org\/10.3390\/biomedicines11061676","journal-title":"Biomedicines"},{"key":"3509_CR7","doi-asserted-by":"publisher","first-page":"308","DOI":"10.1093\/clinchem\/hvaa299","volume":"67","author":"D Collister","year":"2021","unstructured":"Collister D, Mazzetti A, Bhalerao A, Tyrwhitt J, Kavsak P, Brimble KS, Devereaux PJ, Walsh M (2021) Variability in cardiac biomarkers during hemodialysis: a prospective cohort study. Clin Chem 67:308\u2013316. https:\/\/doi.org\/10.1093\/clinchem\/hvaa299","journal-title":"Clin Chem"},{"key":"3509_CR8","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1016\/j.iccl.2023.06.001","volume":"12","author":"EA Eitzman","year":"2023","unstructured":"Eitzman EA, Kroll RG, Yelavarthy P, Sutton NR (2023) Predicting contrast-induced renal complications. Interv Cardiol Clin 12:499\u2013513. https:\/\/doi.org\/10.1016\/j.iccl.2023.06.001","journal-title":"Interv Cardiol Clin"},{"key":"3509_CR9","doi-asserted-by":"publisher","DOI":"10.1155\/2020\/5284728","volume":"2020","author":"Z Gao","year":"2020","unstructured":"Gao Z, Liu Z, Wang R, Zheng Y, Li H, Yang L (2020) Galectin-3 is a potential mediator for atherosclerosis. J Immunol Res 2020:5284728. https:\/\/doi.org\/10.1155\/2020\/5284728","journal-title":"J Immunol Res"},{"key":"3509_CR10","first-page":"181","volume":"103","author":"RG Gerrity","year":"1981","unstructured":"Gerrity RG (1981) The role of the monocyte in atherogenesis: I. Transition of blood-borne monocytes into foam cells in fatty lesions. Am J Pathol 103:181\u2013190","journal-title":"Am J Pathol"},{"key":"3509_CR11","doi-asserted-by":"publisher","first-page":"818","DOI":"10.1161\/HYPERTENSIONAHA.118.11102","volume":"72","author":"R Ghali","year":"2018","unstructured":"Ghali R, Altara R, Louch WE, Cataliotti A, Mallat Z, Kaplan A, Zouein FA, Booz GW (2018) IL-33 (interleukin 33)\/sST2 axis in hypertension and heart failure. Hypertension 72:818\u2013828. https:\/\/doi.org\/10.1161\/HYPERTENSIONAHA.118.11102","journal-title":"Hypertension"},{"key":"3509_CR12","doi-asserted-by":"publisher","unstructured":"Gillham M (2017) Acute renal failure and renal support. In: Cardiothoracic Critical Care. Elsevier, pp 481\u2013494. https:\/\/doi.org\/10.1016\/B978-075067572-7.50036-9","DOI":"10.1016\/B978-075067572-7.50036-9"},{"key":"3509_CR13","doi-asserted-by":"publisher","DOI":"10.1155\/2021\/8881393","volume":"2021","author":"G Guo","year":"2021","unstructured":"Guo G, Huang A, Huang X, Xu T, Yao L (2021) Prognostic value of soluble suppression of tumorigenicity 2 in chronic kidney disease patients: a meta-analysis. Dis Markers 2021:8881393. https:\/\/doi.org\/10.1155\/2021\/8881393","journal-title":"Dis Markers"},{"key":"3509_CR14","first-page":"12","volume":"1","author":"E Habas","year":"2012","unstructured":"Habas E, Rayani A, Khammaj A (2012) Long-term complications of hemodialysis. Sebha Med J 1:12\u201318","journal-title":"Sebha Med J"},{"key":"3509_CR15","doi-asserted-by":"publisher","first-page":"288","DOI":"10.2353\/ajpath.2008.070726","volume":"172","author":"NC Henderson","year":"2008","unstructured":"Henderson NC, Mackinnon AC, Farnworth SL, Kipari T, Haslett C, Iredale JP, Liu FT, Hughes J, Sethi T (2008) Galectin-3 expression and secretion links macrophages to the promotion of renal fibrosis. Am J Pathol 172:288\u2013298. https:\/\/doi.org\/10.2353\/ajpath.2008.070726","journal-title":"Am J Pathol"},{"key":"3509_CR16","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0158765","volume":"11","author":"NR Hill","year":"2016","unstructured":"Hill NR, Fatoba ST, Oke JL, Hirst JA, O\u2019Callaghan CA, Lasserson DS, Hobbs FDR (2016) Global prevalence of chronic kidney disease - a systematic review and meta-analysis. PLoS ONE 11:e0158765. https:\/\/doi.org\/10.1371\/journal.pone.0158765","journal-title":"PLoS ONE"},{"key":"3509_CR17","doi-asserted-by":"publisher","DOI":"10.1016\/j.diabres.2020.108082","volume":"161","author":"S Hussain","year":"2020","unstructured":"Hussain S, Habib A, Hussain MS, Najmi AK (2020) Potential biomarkers for early detection of diabetic kidney disease. Diabetes Res Clin Pract 161:108082. https:\/\/doi.org\/10.1016\/j.diabres.2020.108082","journal-title":"Diabetes Res Clin Pract"},{"key":"3509_CR18","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1016\/j.jacc.2007.05.014","volume":"50","author":"JL Januzzi Jr","year":"2007","unstructured":"Januzzi JL Jr, Peacock WF, Maisel AS, Chae CU, Jesse RL, Baggish AL, O\u2019Donoghue M, Sakhuja R, Chen AA, van Kimmenade RR, Lewandrowski KB, Lloyd-Jones DM, Wu AHB (2007) Measurement of the interleukin family member ST2 in patients with acute dyspnea: results from the PRIDE (Pro-Brain Natriuretic Peptide Investigation of Dyspnea in the Emergency Department) study. J Am Coll Cardiol 50:607\u2013613. https:\/\/doi.org\/10.1016\/j.jacc.2007.05.014","journal-title":"J Am Coll Cardiol"},{"key":"3509_CR19","first-page":"2374","volume":"9","author":"CM John","year":"2003","unstructured":"John CM, Leffler H, Kahl-Knutsson B, Svensson I, Jarvis GA (2003) Truncated galectin-3 inhibits tumor growth and metastasis in orthotopic nude mouse model of human breast cancer. Clin Cancer Res 9:2374\u20132383","journal-title":"Clin Cancer Res"},{"key":"3509_CR20","doi-asserted-by":"publisher","first-page":"1568","DOI":"10.1182\/blood-2017-12-819904","volume":"131","author":"E Kastritis","year":"2018","unstructured":"Kastritis E, Papassotiriou I, Merlini G, Milani P, Terpos E, Basset M, Akalestos A, Russo F, Psimenou E, Apostolakou F, Roussou M, Gavriatopoulou M, Eleutherakis-Papaiakovou E, Fotiou D, Ziogas DC, Papadopoulou E, Pamboucas C, Dimopoulos MA, Palladini G (2018) Growth differentiation factor-15 is a new biomarker for survival and renal outcomes in light chain amyloidosis. Blood 131:1568\u20131575. https:\/\/doi.org\/10.1182\/blood-2017-12-819904","journal-title":"Blood"},{"key":"3509_CR21","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1161\/01.RES.0000202805.73038.48","volume":"98","author":"T Kempf","year":"2006","unstructured":"Kempf T, Eden M, Strelau J, Naguib M, Willenbockel C, Tongers J, Heineke J, Kotlarz D, Xu J, Molkentin JD, Niessen HW, Drexler H, Wollert KC (2006) The transforming growth factor-beta superfamily member growth-differentiation factor-15 protects the heart from ischemia\/reperfusion injury. Circ Res 98:351\u2013360. https:\/\/doi.org\/10.1161\/01.RES.0000202805.73038.48","journal-title":"Circ Res"},{"key":"3509_CR22","doi-asserted-by":"publisher","first-page":"602","DOI":"10.1093\/ndt\/gfg603","volume":"19","author":"Y Kikuchi","year":"2004","unstructured":"Kikuchi Y, Kobayashi S, Nagao K, Sugiyama H, Kudo A, Takizawa T, Wada N, Kihara I (2004) Galectin-3-positive cell infiltration in human diabetic nephropathy. Nephrol Dial Transplant 19:602\u2013607. https:\/\/doi.org\/10.1093\/ndt\/gfg603","journal-title":"Nephrol Dial Transplant"},{"key":"3509_CR23","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1159\/000498959","volume":"44","author":"JS Kim","year":"2019","unstructured":"Kim JS, Kim S, Won CW, Jeong KH (2019) Association between plasma levels of growth differentiation factor-15 and renal function in the elderly: Korean frailty and aging cohort study. Kidney Blood Press Res 44:405\u2013414. https:\/\/doi.org\/10.1159\/000498959","journal-title":"Kidney Blood Press Res"},{"key":"3509_CR24","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0018683","volume":"6","author":"M Kolatsi-Joannou","year":"2011","unstructured":"Kolatsi-Joannou M, Price KL, Winyard PJ, Long DA (2011) Modified citrus pectin reduces galectin-3 expression and disease severity in experimental acute kidney injury. PLoS ONE 6:e18683. https:\/\/doi.org\/10.1371\/journal.pone.0018683","journal-title":"PLoS ONE"},{"key":"3509_CR25","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1111\/j.1540-8175.1999.tb00804.x","volume":"16","author":"MC Kontos","year":"1999","unstructured":"Kontos MC (1999) Role of echocardiography in the emergency department for identifying patients with myocardial infarction and ischemia. Echocardiography 16:193\u2013205. https:\/\/doi.org\/10.1111\/j.1540-8175.1999.tb00804.x","journal-title":"Echocardiography"},{"key":"3509_CR26","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/s0378-1119(97)00485-x","volume":"203","author":"LN Lawton","year":"1997","unstructured":"Lawton LN, Bonaldo MF, Jelenc PC, Qiu L, Baumes SA, Marcelino RA, de Jesus GM, Wellington S, Knowles JA, Warburton D, Brown S, Soares MB (1997) Identification of a novel member of the TGF-beta superfamily highly expressed in human placenta. Gene 203:17\u201326. https:\/\/doi.org\/10.1016\/s0378-1119(97)00485-x","journal-title":"Gene"},{"key":"3509_CR27","doi-asserted-by":"publisher","first-page":"H404","DOI":"10.1152\/ajpheart.00747.2008","volume":"296","author":"YH Liu","year":"2009","unstructured":"Liu YH, D\u2019Ambrosio M, Liao TD, Peng H, Rhaleb NE, Sharma U, Andr\u00e9 S, Gabius HJ, Carretero OA (2009) N-acetyl-seryl-aspartyl-lysyl-proline prevents cardiac remodeling and dysfunction induced by galectin-3, a mammalian adhesion\/growth-regulatory lectin. Am J Physiol Heart Circ Physiol 296:H404\u2013H412. https:\/\/doi.org\/10.1152\/ajpheart.00747.2008","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"3509_CR28","doi-asserted-by":"publisher","first-page":"701","DOI":"10.1681\/ASN.2019090876","volume":"31","author":"J Liu","year":"2020","unstructured":"Liu J, Kumar S, Heinzel A, Gao M, Guo J, Alvarado GF, Reindl-Schwaighofer R, Krautzberger AM, Cipp\u00e0 PE, McMahon J, Oberbauer R, McMahon AP (2020) Renoprotective and immunomodulatory effects of GDF15 following AKI invoked by ischemia-reperfusion injury. J Am Soc Nephrol 31:701\u2013715. https:\/\/doi.org\/10.1681\/ASN.2019090876","journal-title":"J Am Soc Nephrol"},{"key":"3509_CR29","doi-asserted-by":"publisher","first-page":"379","DOI":"10.2215\/CJN.07500715","volume":"11","author":"J Lunyera","year":"2016","unstructured":"Lunyera J, Mohottige D, Von Isenburg M, Jeuland M, Patel UD, Stanifer JW (2016) CKD of uncertain etiology: a systematic review. Clin J Am Soc Nephrol 11:379\u2013385. https:\/\/doi.org\/10.2215\/CJN.07500715","journal-title":"Clin J Am Soc Nephrol"},{"key":"3509_CR30","doi-asserted-by":"publisher","first-page":"143","DOI":"10.4103\/0971-4065.139489","volume":"25","author":"KU Maheshwari","year":"2015","unstructured":"Maheshwari KU, Santhi S, Malar RJ (2015) Cystatin C: an alternative dialysis adequacy marker in high flux hemodialysis. Indian J Nephrol 25:143\u2013145. https:\/\/doi.org\/10.4103\/0971-4065.139489","journal-title":"Indian J Nephrol"},{"key":"3509_CR31","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1159\/000515675","volume":"51","author":"N Mancianti","year":"2022","unstructured":"Mancianti N, Maresca B, Palladino M, Salerno G, Cardelli P, Men\u00e8 P, Barberi S (2022) Serum cardiac biomarkers in asymptomatic hemodialysis patients: role of soluble suppression of tumorigenicity-2. Blood Purif 51:155\u2013162. https:\/\/doi.org\/10.1159\/000515675","journal-title":"Blood Purif"},{"key":"3509_CR32","doi-asserted-by":"publisher","first-page":"924","DOI":"10.1080\/00015385.2024.2309999","volume":"79","author":"S Matyar","year":"2024","unstructured":"Matyar S, A\u00e7\u0131kal\u0131n Akp\u0131nar A, Di\u015fel NR, Avci A, \u00c7a\u011flayan \u00c7E, Y\u0131ld\u0131r\u0131m A, Akp\u0131nar O (2024) Prognostic value of sST2 in long-term mortality in acute heart failure. Acta Cardiol 79:924\u2013934. https:\/\/doi.org\/10.1080\/00015385.2024.2309999","journal-title":"Acta Cardiol"},{"key":"3509_CR33","doi-asserted-by":"publisher","first-page":"F1249","DOI":"10.1152\/ajprenal.00387.2013","volume":"305","author":"M Mazagova","year":"2013","unstructured":"Mazagova M, Buikema H, van Buiten A, Duin M, Goris M, Sandovici M, Henning RH, Deelman LE (2013) Genetic deletion of growth differentiation factor 15 augments renal damage in both type 1 and type 2 models of diabetes. Am J Physiol Renal Physiol 305:F1249\u2013F1264. https:\/\/doi.org\/10.1152\/ajprenal.00387.2013","journal-title":"Am J Physiol Renal Physiol"},{"key":"3509_CR34","doi-asserted-by":"publisher","first-page":"1163","DOI":"10.1016\/j.clinbiochem.2015.07.031","volume":"48","author":"T Mueller","year":"2015","unstructured":"Mueller T, Gegenhuber A, Kronabethleitner G, Leitner I, Haltmayer M, Dieplinger B (2015) Plasma concentrations of novel cardiac biomarkers before and after hemodialysis session. Clin Biochem 48:1163\u20131166. https:\/\/doi.org\/10.1016\/j.clinbiochem.2015.07.031","journal-title":"Clin Biochem"},{"key":"3509_CR35","doi-asserted-by":"publisher","first-page":"442","DOI":"10.2215\/CJN.04580415","volume":"11","author":"RA Mustafa","year":"2016","unstructured":"Mustafa RA, Bdair F, Akl EA, Garg AX, Thiessen-Philbrook H, Salameh H, Kisra S, Nesrallah G, Al-Jaishi A, Patel P, Patel P, Mustafa AA, Sch\u00fcnemann HJ (2016) Effect of lowering the dialysate temperature in chronic hemodialysis: a systematic review and meta-analysis. Clin J Am Soc Nephrol 11:442\u2013457. https:\/\/doi.org\/10.2215\/CJN.04580415","journal-title":"Clin J Am Soc Nephrol"},{"key":"3509_CR36","first-page":"1199","volume":"152","author":"M Nachtigal","year":"1998","unstructured":"Nachtigal M, Al-Assaad Z, Mayer EP, Kim K, Monsigny M (1998) Galectin-3 expression in human atherosclerotic lesions. Am J Pathol 152:1199\u20131208","journal-title":"Am J Pathol"},{"key":"3509_CR37","doi-asserted-by":"publisher","first-page":"884","DOI":"10.1053\/j.ajkd.2015.07.015","volume":"66","author":"National Kidney Foundation","year":"2015","unstructured":"National Kidney Foundation (2015) KDOQI clinical practice guideline for hemodialysis adequacy: 2015 update. Am J Kidney Dis 66:884\u2013930. https:\/\/doi.org\/10.1053\/j.ajkd.2015.07.015","journal-title":"Am J Kidney Dis"},{"key":"3509_CR38","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/j.ahj.2016.05.018","volume":"179","author":"M Obokata","year":"2016","unstructured":"Obokata M, Sunaga H, Ishida H, Ito K, Ogawa T, Ando Y, Kurabayashi M, Negishi K (2016) Independent and incremental prognostic value of novel cardiac biomarkers in chronic hemodialysis patients. Am Heart J 179:29\u201341. https:\/\/doi.org\/10.1016\/j.ahj.2016.05.018","journal-title":"Am Heart J"},{"key":"3509_CR39","doi-asserted-by":"publisher","first-page":"1131","DOI":"10.1111\/nep.13179","volume":"23","author":"MA Roberts","year":"2018","unstructured":"Roberts MA, Srivastava PM, Hare DL, Ierino FL (2018) Effect of haemodialysis and residual renal function on serum levels of galectin-3, B-type natriuretic peptides and cardiac troponin T. Nephrology (Carlton) 23:1131\u20131138. https:\/\/doi.org\/10.1111\/nep.13179","journal-title":"Nephrology (Carlton)"},{"key":"3509_CR40","doi-asserted-by":"publisher","first-page":"1538","DOI":"10.1172\/JCI30634","volume":"117","author":"S Sanada","year":"2007","unstructured":"Sanada S, Hakuno D, Higgins LJ, Schreiter ER, McKenzie AN, Lee RT (2007) IL-33 and ST2 comprise a critical biomechanically induced and cardioprotective signaling system. J Clin Invest 117:1538\u20131549. https:\/\/doi.org\/10.1172\/JCI30634","journal-title":"J Clin Invest"},{"key":"3509_CR41","doi-asserted-by":"publisher","first-page":"3970","DOI":"10.3390\/jcm12123970","volume":"12","author":"E Sciatti","year":"2023","unstructured":"Sciatti E, Merlo A, Scangiuzzi C, Limonta R, Gori M, D\u2019Elia E, Aimo A, Vergaro G, Emdin M, Senni M (2023) Prognostic value of sST2 in heart failure. J Clin Med 12:3970. https:\/\/doi.org\/10.3390\/jcm12123970","journal-title":"J Clin Med"},{"key":"3509_CR42","doi-asserted-by":"publisher","first-page":"3121","DOI":"10.1161\/01.CIR.0000147181.65298.4D","volume":"110","author":"UC Sharma","year":"2004","unstructured":"Sharma UC, Pokharel S, van Brakel T, van Berlo JH, Cleutjens JPM, Schroen B, Andr\u00e9 S, Crijns H, Gabius HJ, Maessen J, Pinto Y (2004) Galectin-3 marks activated macrophages in failure-prone hypertrophied hearts and contributes to cardiac dysfunction. Circulation 110:3121\u20133128. https:\/\/doi.org\/10.1161\/01.CIR.0000147181.65298.4D","journal-title":"Circulation"},{"key":"3509_CR43","doi-asserted-by":"publisher","first-page":"2186","DOI":"10.1161\/01.CIR.0000127958.21003.5A","volume":"109","author":"M Shimpo","year":"2004","unstructured":"Shimpo M, Morrow DA, Weinberg EO, Sabatine MS, Murphy SA, Antman EM, Lee RT (2004) Serum levels of the interleukin-1 receptor family member ST2 predict mortality and clinical outcome in acute myocardial infarction. Circulation 109:2186\u20132190. https:\/\/doi.org\/10.1161\/01.CIR.0000127958.21003.5A","journal-title":"Circulation"},{"key":"3509_CR44","doi-asserted-by":"publisher","first-page":"1096","DOI":"10.1177\/2047487314550013","volume":"22","author":"V Srivatsan","year":"2015","unstructured":"Srivatsan V, George M, Shanmugam E (2015) Utility of galectin-3 as a prognostic biomarker in heart failure: where do we stand? Eur J Prev Cardiol 22:1096\u20131110. https:\/\/doi.org\/10.1177\/2047487314550013","journal-title":"Eur J Prev Cardiol"},{"key":"3509_CR45","doi-asserted-by":"publisher","first-page":"4180","DOI":"10.1093\/ndt\/gfs021","volume":"27","author":"F Tentori","year":"2012","unstructured":"Tentori F, Zhang J, Li Y, Karaboyas A, Kerr P, Saran R, Bommer J, Port F, Akiba T, Pisoni R, Robinson B (2012) Longer dialysis session length is associated with better intermediate outcomes and survival among patients on in-center three times per week hemodialysis: results from the Dialysis Outcomes and Practice Patterns Study (DOPPS). Nephrol Dial Transplant 27:4180\u20134188. https:\/\/doi.org\/10.1093\/ndt\/gfs021","journal-title":"Nephrol Dial Transplant"},{"key":"3509_CR46","unstructured":"Vaidya SR, Aeddula NR (2024) Chronic kidney disease. In: StatPearls [Internet]. StatPearls Publishing, Treasure Island (FL). Available from: https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK535404\/"},{"key":"3509_CR47","doi-asserted-by":"publisher","first-page":"563","DOI":"10.5603\/CJ.a2016.0061","volume":"23","author":"CH Wang","year":"2016","unstructured":"Wang CH, Yang NI, Liu MH, Hsu KH, Kuo LT (2016) Estimating systemic fibrosis by combining galectin-3 and ST2 provides powerful risk stratification value for patients after acute decompensated heart failure. Cardiol J 23:563\u2013572. https:\/\/doi.org\/10.5603\/CJ.a2016.0061","journal-title":"Cardiol J"},{"issue":"1","key":"3509_CR48","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1111\/1744-9987.12294","volume":"19","author":"Y Watanabe","year":"2015","unstructured":"Watanabe Y, Kawanishi H, Suzuki K, Nakai S, Tsuchida K, Tabei K, Akiba T, Masakane I, Takemoto Y, Tomo T, Itami N, Komatsu Y, Hattori M, Mineshima M, Yamashita A, Saito A, Naito H, Hirakata H, Minakuchi J, Maintenance Hemodialysis: Hemodialysis Prescriptions\u201d Guideline Working Group, Japanese Society for Dialysis Therapy (2015) Japanese society for dialysis therapy clinical guideline for \u201cMaintenance hemodialysis: hemodialysis prescriptions.\u201d Ther Apher Dial 19(1):67\u201392. https:\/\/doi.org\/10.1111\/1744-9987.12294","journal-title":"Ther Apher Dial"},{"key":"3509_CR49","doi-asserted-by":"publisher","first-page":"2961","DOI":"10.1161\/01.cir.0000038705.69871.d9","volume":"106","author":"EO Weinberg","year":"2002","unstructured":"Weinberg EO, Shimpo M, De Keulenaer GW, MacGillivray C, Tominaga S, Solomon SD, Rouleau JL, Lee RT (2002) Expression and regulation of ST2, an interleukin-1 receptor family member, in cardiomyocytes and myocardial infarction. Circulation 106:2961\u20132966. https:\/\/doi.org\/10.1161\/01.cir.0000038705.69871.d9","journal-title":"Circulation"},{"key":"3509_CR50","doi-asserted-by":"publisher","first-page":"721","DOI":"10.1161\/01.cir.0000047274.66749.fe","volume":"107","author":"EO Weinberg","year":"2003","unstructured":"Weinberg EO, Shimpo M, Hurwitz S, Tominaga S, Rouleau JL, Lee RT (2003) Identification of serum soluble ST2 receptor as a novel heart failure biomarker. Circulation 107:721\u2013726. https:\/\/doi.org\/10.1161\/01.cir.0000047274.66749.fe","journal-title":"Circulation"},{"issue":"1","key":"3509_CR51","doi-asserted-by":"publisher","first-page":"S1","DOI":"10.1517\/14622416.2.1.S1","volume":"2","author":"BR Winkelmann","year":"2001","unstructured":"Winkelmann BR, M\u00e4rz W, Boehm BO, Zotz R, Hager J, Hellstern P, Senges J, LURIC Study Group (2001) Rationale and design of the LURIC study \u2013 a resource for functional genomics, pharmacogenomics and long-term prognosis of cardiovascular disease. Pharmacogenomics 2(1):S1\u2013S73. https:\/\/doi.org\/10.1517\/14622416.2.1.S1","journal-title":"Pharmacogenomics"}],"container-title":["Amino Acids"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00726-026-03509-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00726-026-03509-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00726-026-03509-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,19]],"date-time":"2026-03-19T13:25:10Z","timestamp":1773926710000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00726-026-03509-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,13]]},"references-count":51,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["3509"],"URL":"https:\/\/doi.org\/10.1007\/s00726-026-03509-1","relation":{},"ISSN":["1438-2199"],"issn-type":[{"value":"1438-2199","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,13]]},"assertion":[{"value":"11 July 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 February 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 March 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of Interest"}},{"value":"The authors declare no conflicts of interest.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Written informed consent has been obtained from the.patient.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}],"article-number":"21"}}